Janssen Receives Positive CHMP Opinion Recommending CARVYKTI

Ciltacabtagene autoleucel (cilta-cel), Janssen's first cell therapy, is a structurally differentiated CAR-T with two BCMA-targeting single domain antibodies The Janssen Pharmaceutical Companies of Johnson

Related Keywords

Japan , China , United States , Chinese , American , Ciltacabtagene Autoleucel , Jenni Mildon , Edmond Chan Mbch , Sen Zhuang , American Society Of Clinical Oncology , Janssen Biotech Inc , Oncology Clinical Research , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , American Society Of Hematology , Committee For Medicinal Products Human Use , American Cancer Society , None Of The Janssen Pharmaceutical Companies , Drug Administration , European Commission , Medicinal Devices Agency , Exchange Commission , Companies Of Johnson , European Medicines Agency , Johnson , Legend Biotech United States Inc , Medicinal Products , Human Use , Janssen Biotech , Legend Biotech United States , Edmond Chan , Area Lead Haematology , American Society , Vice President , Legend Biotech , Marketing Authorisation Application , Breakthrough Therapy Designation , Orphan Drug Designation , Multiple Myeloma , Pharmaceutical Companies , Cardiovascular Metabolism , Infectious Diseases Vaccines , Janssen Cilag Limited , Concerning Forward Looking Statements , Private Securities Litigation Reform Act , Janssen Pharmaceutica , Annual Report , Note Regarding Forward Looking , Quarterly Reports , Janssen Enters Worldwide Collaboration , License Agreement , Chinese Company Legend Biotech , Develop Investigational , Results From , Patients With , Refractory Multiple , Annual Meeting Exposition , Triple Class Exposed Patients With Relapsed , Refractory Multiple Myeloma , Findings From , Clin Cancer , Potential Uses , Today Population Factsheets , Janssen , Eceives , Positive , Thmp , Opinion , Recommending , Carvykti , Ciltacabtagene , Utoleucel , Treatment , Patients , Relapsed , Refractory , Multiple , Myeloma ,